Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation-Reference-Cited by-同舟云学术

Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation

Published:2021-01-01 Issue:1 Volume:36 Page:1377-1385
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Salerno Loredana¹^ORCID,Vanella Luca¹^ORCID,Sorrenti Valeria¹^ORCID,Consoli Valeria¹^ORCID,Ciaffaglione Valeria¹^ORCID,Fallica Antonino N.¹^ORCID,Canale Vittorio²^ORCID,Zajdel Paweł²^ORCID,Pignatello Rosario¹^ORCID,Intagliata Sebastiano¹^ORCID

Affiliation:

1. Department of Drug and Health Sciences, University of Catania, Catania, Italy

2. Department of Organic Chemistry, Jagiellonian University Medical College, Kraków, Poland

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1928111

Reference49 articles.

1. 5-Fluorouracil: mechanisms of action and clinical strategies

2. Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy